Steris plc, IE00BFY8C754

STERIS CFO reported 228 shares withheld from STERIS stock

Published on 10/08/2026 at 11:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

STERIS stock costs EUR 186.55 on October 8, 2026 after EUR 187.30. First-quarter fiscal 2027 revenue rose 7.30 percent to USD 1.49 billion.

Börsen-Editorialfoto mit Händlern vor Bildschirmen und steigenden Charts im Gesundheitssektor
Steris plc IE00BFY8C754 wird redaktionell am Börsenparkett der NYSE mit steigenden Healthcare-Sektor-Charts abgebildet, Illustration mit AI erstellt.

STERIS plc (IE00BFY8C754) stock was trading at EUR 186.55 at Lang & Schwarz on October 8, 2026 at 11:39 a.m. CEST. The latest filing said CFO Karen L. Burton had 228 ordinary shares withheld for taxes from 783 restricted shares that vested on October 1, 2026, according to StockTitan. The filing also reported 12,956 ordinary shares held directly after the transaction.

Filing puts insider activity in view

The tax withholding was an administrative transaction rather than an open-market sale. The Form 4 listed the withheld shares at USD 0.00 because the shares represented taxes due on the vesting event, not a cash sale at that price.

For investors, the more relevant figure is the 8,499 restricted shares reported as of October 2, 2026. The filing states that restrictions on those shares lapse across dates from June 2, 2027, through October 1, 2028, which separates the filing from a broad change in insider ownership.

Revenue growth sets the baseline

STERIS reported USD 1.49 billion of revenue in the first quarter of fiscal 2027, up 7.30 percent from the prior-year quarter, according to MarketBeat. Quarterly earnings per share reached USD 2.59, topping the cited consensus estimate of USD 2.49 by USD 0.10.

The company set fiscal 2027 earnings-per-share guidance at USD 11.00 to USD 11.30 in the same reported context. That operating comparison gives the filing a narrower investor impact than the companys quarterly revenue and earnings trajectory.

Valuation remains tied to November results

STERIS had a market capitalization of USD 20.4 billion as of October 8, 2026. Its 52-week range was USD 195.14 to USD 269.44, placing the latest primary-market context below the yearly high without mixing it with the euro reference quote.

Yahoo Finance listed November 4, 2026 as the estimated next earnings date. The next report will give investors a fresh test of whether the 7.30 percent first-quarter revenue increase is carrying into the second quarter of fiscal 2027.

Euro quote stays below the prior close

The Lang & Schwarz price of EUR 186.55 was down 0.40 percent versus the prior close of EUR 187.30 on October 8, 2026. The company is listed on the NYSE under ticker STE, while STERIS provides infection prevention, sterilization and surgical products and services across healthcare and life sciences.

The further course of trading is shown by the continuously updated real-time quote of Steris plc stock.

STERIS plc stock facts

  • Company: STERIS plc
  • ISIN: IE00BFY8C754
  • Ticker: STE
  • Primary exchange: NYSE
  • Price Lang & Schwarz as of October 8, 2026, 11:39 a.m. CEST: EUR 186.55
  • Change versus prior close: minus 0.40 percent
  • Prior close Lang & Schwarz October 7, 2026: EUR 187.30
  • Market capitalization: USD 20.4 billion as of October 8, 2026
  • 52-week range: USD 195.14-269.44 as of October 8, 2026
  • Sector / Industry: Healthcare / Medical Devices
  • Next earnings date: November 4, 2026

More news and analyses on Steris plc stock

Disclaimer...

en | IE00BFY8C754 | STERIS PLC | boerse | 70264969 | bgmi